The tumor-derived sEVs also led to hypersensitivity through an autotaxin (ATX)-enzyme synthetizing lysophosphatidic acid (LPA)-LPA receptor (LPAR)-dependent manner in bone cancer pain [104]. Here, ENPP2 is linked to neoplasm.